GGrantIndex
← Leaderboards

David E Avigan

Beth Israel Deaconess Medical Center

$5,917,131
Attributed
$7,788,104
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY201725
$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,788,104 · 6

By mechanism

R01$6,946,602 · 3
R21$841,502 · 2
M01$0 · 1

Top collaborators

Most similar at Beth Israel Deaconess Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Toxic Effect

Research focus

Toxic EffectResponseNeoplastic CellVaccinesPathway InteractionsLeukemiaTumorMediatingAntigensPreventImmuneDisease RemissionElementsT-LymphocyteBone MarrowCharacteristicsClinical ResearchPhenotypeRelapseHeterogeneityAreaAutologousCell FusionChemotherapy

Grant awards (19)

Personalized Adoptive T-cell Therapy for AML$728,501
R01 · FY2025 · CA · contact PI
Personalized Adoptive T-cell Therapy for AML$692,077
R01 · FY2024 · CA · contact PI
Personalized Adoptive T-cell Therapy for AML$717,103
R01 · FY2022 · CA · contact PI
Personalized vaccine for patients with AML$653,338
R01 · FY2022 · CA · contact PI
Personalized Adoptive T-cell Therapy for AML$762,763
R01 · FY2021 · CA · contact PI
High-efficiency microfluidic cell fusion for dendritic cell/tumor cell vaccine production$428,524
R21 · FY2021 · CA
Personalized vaccine for patients with AML$54,507
R01 · FY2021 · CA · contact PI
Personalized vaccine for patients with AML$721,179
R01 · FY2020 · CA · contact PI
Targeting PML for Leukemia Therapy$456,984
R01 · FY2020 · CA · contact PI
Personalized vaccine for patients with AML$699,542
R01 · FY2019 · CA · contact PI
Directed Purinergic Signaling as Immunotherapy in Leukemia$184,603
R21 · FY2019 · CA
Personalized vaccine for patients with AML$721,179
R01 · FY2018 · CA · contact PI
Directed Purinergic Signaling as Immunotherapy in Leukemia$228,375
R21 · FY2018 · CA
Personalized vaccine for patients with AML$739,429
R01 · FY2017 · CA · contact PI
POST TRANSPLANT RHIL 12--BREAST CANCER THERAPY$0
M01 · FY2002 · RR
POST TRANSPLANT RHIL 12--BREAST CANCER THERAPY$0
M01 · FY2001 · RR
POST TRANSPLANT RHIL 12--BREAST CANCER THERAPY$0
M01 · FY2000 · RR
POST TRANSPLANT RHIL 12--BREAST CANCER THERAPY$0
M01 · FY2000 · RR
POST TRANSPLANT RHIL 12--BREAST CANCER THERAPY$0
M01 · FY2000 · RR